Anterior gradient 2: a novel player in tumor cell biology.

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

BRYCHTOVÁ Veronika VOJTĚŠEK Bořivoj HRSTKA Roman

Year of publication 2011
Type Article in Periodical
Magazine / Source Cancer Letters
MU Faculty or unit

Faculty of Medicine

Citation
Web http://www.cancerletters.info/article/S0304-3835%2811%2900015-2/abstract
Doi http://dx.doi.org/10.1016/j.canlet.2010.12.023
Field Genetics and molecular biology
Keywords AGR2; Tumor metastasis; Breast cancer; Pancreatic cancer; Barrett esophagus
Description AGR2 has evolutionarily conserved roles in development and tissue regeneration and is linked with several human cancers. The exact functions and regulation of AGR2 are poorly understood, but current data identify AGR2 as a clinically relevant factor that modulates the behavior and response of hormone-dependent cancers (breast, prostate) and hormone-independent cancers (colorectal, pancreatic, esophageal and other common cancers). AGR2 protein expression induces metastasis, acts as a p53 tumor suppressor inhibitor and survival factor, participates directly in neoplastic transformation and is involved in drug resistance. Thus, AGR2 is an important tumor biomarker and negative prognostic factor potentially exploitable in clinical practice.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.